New diabetes clinical trial: A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus
Published on: 2026-11-06T05:00:00Z Conditions : Type 2 Diabetes Mellitus (T2DM); Type 2 Diabetes; T2DM Interventions : Drug: SAL0150 dose 1; Drug: SAL0150 dose 2; Drug: SAL0150 dose 2; Drug: SAL0150 dose 3; Drug: SAL0150 dose 3; Drug: Placebo; Drug: Semaglutide inject 1.0 mg Sponsors : Shenzhen Salubris Pharmaceuticals Co., Ltd. Not yet recruiting https://ift.tt/qlNZG0s